Albert D. Mason Inc’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Buy
6,037
+27
+0.4% +$7.47K 0.76% 52
2026
Q1
$1.78M Buy
6,010
+81
+1% +$24.1K 1.15% 27
2025
Q4
$1.62M Buy
5,929
+28
+0.5% +$7.61K 1.07% 34
2025
Q3
$1.59M Buy
5,901
+361
+7% +$98.2K 1.04% 35
2025
Q2
$1.53M Sell
5,540
-433
-7% -$118K 1.11% 28
2025
Q1
$1.58M Buy
+5,973
New +$1.47M 1.08% 29

Other funds holding CME

Albert D. Mason Inc's CME Position: Q2 2026 in Review

Albert D. Mason Inc increased its CME Group (CME) stake by 0.45% in Q2 2026, buying an estimated $7.47K and bringing the position to 6,037 shares worth $1.33M. The position accounts for 0.76% of the portfolio, ranked #52.

Albert D. Mason Inc first reported a position in CME in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.78M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Albert D. Mason Inc held 6,037 shares of CME Group worth $1.33M as of Q2 2026.
  • Albert D. Mason Inc bought 27 CME Group shares in Q2 2026, an estimated $7.47K.
  • CME Group made up 0.76% of Albert D. Mason Inc's portfolio in Q2 2026, its #52 holding.
  • Albert D. Mason Inc first reported a position in CME Group in Q1 2025 and has held it in 6 quarters since.
  • Albert D. Mason Inc's CME Group position peaked at $1.78M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Albert D. Mason Inc's 13F filing for Q2 2026, filed 22 Jul 2026.